These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22217481)

  • 1. Tackling myocardial metabolism: one year evaluation of free fatty acids, norephinephrine and NT-proBNP in ventricular fibrillation during STEMI.
    Behnes M; Kälsch T; Lang S; Süselbeck T; Borggrefe M; Elmas E
    Int J Cardiol; 2012 Mar; 155(2):291-3. PubMed ID: 22217481
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of N-terminal pro-brain natriuretic peptide in ST-segment elevation myocardial infarction: experience from a tertiary centre in India.
    Govind SC; Kiotsekoglou A; Gadiyaram VK; Gopal AS; Brodin LÅ; Ramesh SS; Saha SK
    Crit Pathw Cardiol; 2011 Dec; 10(4):180-4. PubMed ID: 22089274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P; Balmelli C; Reichlin T; Twerenbold R; Reiter M; Meissner J; Schaub N; Stelzig C; Freese M; Paniz P; Meune C; Drexler B; Freidank H; Winkler K; Hochholzer W; Mueller C
    Am J Med; 2011 Aug; 124(8):731-9. PubMed ID: 21787902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers.
    Valente S; Lazzeri C; Chiostri M; Giglioli C; Sori A; Tigli S; Gensini GF
    Int J Cardiol; 2009 Feb; 132(1):84-9. PubMed ID: 18207587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction.
    Lorgis L; Cottin Y; Danchin N; Mock L; Sicard P; Buffet P; L'huillier I; Richard C; Beer JC; Touzery C; Gambert P; Zeller M;
    Heart; 2011 Apr; 97(7):551-6. PubMed ID: 21343169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
    J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Circulation; 2005 Jul; 112(1):110-6. PubMed ID: 15983245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels 3 months after myocardial infarction are more strongly associated with magnetic resonance-determined ejection fraction than NTproBNP levels in the acute phase.
    Mistry N; Abdelnoor M; Seljeflot I; Hoffmann P; Bøhmer E; Bjørnerheim R; Kjeldsen SE; Halvorsen S
    J Card Fail; 2011 Jun; 17(6):479-86. PubMed ID: 21624736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
    Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B;
    Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unrecognized myocardial scars detected by delayed-enhanced MRI are associated with increased levels of NT-proBNP.
    Themudo RE; Lindahl B; Johansson L; Venge P; Ahlström H; Ebeling Barbier C; Eggers KM; Lind L; Bjerner T
    Coron Artery Dis; 2011 May; 22(3):158-64. PubMed ID: 21200318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
    Giallauria F; Cirillo P; Lucci R; Pacileo M; De Lorenzo A; D'Agostino M; Moschella S; Psaroudaki M; Del Forno D; Orio F; Vitale DF; Chiariello M; Vigorito C
    Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):113-8. PubMed ID: 18277196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
    Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
    J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum NT-proBNP concentrations in the early phase do not predict the severity of systolic or diastolic left ventricular dysfunction among patients with ST-elevation acute myocardial infarction.
    Ben-Dor I; Haim M; Rechavia E; Murninkas D; Harell D; Porter A; Iakobishvili Z; Battler A; Hasdai D
    Angiology; 2006 Dec-2007 Jan; 57(6):686-93. PubMed ID: 17235108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
    Iltumur K; Yavavli A; Apak I; Ariturk Z; Toprak N
    Am Heart J; 2006 May; 151(5):1115-22. PubMed ID: 16644347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
    Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
    J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
    Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
    J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.